Search results
Steps To-Marrow: Grandmother walks hundreds of miles to raise donor awareness
The Wenatchee World· 6 hours agoJeana Moore, 71, is not singing “I’m Gonna Be,” but she is walking hundreds of miles, thousands one...
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 6 days agoResearchers in the US have developed a molecule that “appears to annihilate all solid tumours” in...
Four red flag symptoms of ‘preventable’ silent killer cancer to spot
Daily Express· 14 hours agoPeople are being urged to look out for the telltale signs of a sometimes “silent” cancer that is...
Are You Getting Enough Iodine From Your Diet?
Mercola· 2 days agoUnfortunately, data collected by the U.S. National Health and Nutrition Examination Survey has revealed a significant drop in median urine iodine values.1 The median iodine level measured in ...
Biohaven doses first subject in Phase I/II tumour treatment study
Clinical Trials Arena via Yahoo Finance· 7 days ago“With the initiation of this monotherapy study, we are one step closer to providing differentiated...
A Startling New Study Found That 75% of Past COVID Patients May Suffer From This Heart Condition
Parade· 13 hours agoA new study of 200 COVID-19 patients between the ages of 18 and 83 revealed that more than 75% of...
Cell therapy reckoning: How to get cell therapies flying off-the-shelf
FierceBiotech· 6 days agoThis story is the final part of a four-part series about cell therapy created by the Fierce Biotech...
Penn Medicine Presenters at the American Transplan | Newswise
Newswise· 7 days agoLeading experts in transplant from Penn Medicine will converge in the Pennsylvania Convention Center in Philadelphia from June 1-5 for the American Transpl
KARE 11 Investigates: Family seeks answers after mysterious death behind bars
KARE 11 Minneapolis-St. Paul· 6 days agoA family is grappling with grief and searching for answers about the death of their loved one, Nick...
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R)...
Digital Journal· 3 days agoAt a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk ...